| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 09/11/2003 | US20030170381 Piezoelectric element and process for production thereof |
| 09/11/2003 | US20030168657 Reactive mesogenic azulenes |
| 09/10/2003 | EP1341786A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 09/10/2003 | EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 09/10/2003 | EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 09/10/2003 | EP1341754A1 Substituted anthranilic acids |
| 09/10/2003 | EP1341534A2 Compounds having fungicidal activity and processes to make and use same |
| 09/10/2003 | EP0991619B1 Inhibitors of alpha 4-beta 1 mediated cell adhesion |
| 09/10/2003 | EP0983236B1 Process for the preparation of an oxirane, aziridine or cyclopropane |
| 09/10/2003 | EP0942938B1 Supported catalyst system, method for the production and use thereof in olefin polymerization |
| 09/10/2003 | EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 09/10/2003 | CN1441800A Beta 3 adrenergic agonists |
| 09/10/2003 | CN1441798A Thiophene vitamine A |
| 09/10/2003 | CN1441775A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 09/10/2003 | CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents |
| 09/09/2003 | US6617351 Amide, carbamate, and urea derivatives |
| 09/09/2003 | CA2037114C N-cycloalkylalkylamines, their process of preparation, their use as medication and their synthetic intermediates |
| 09/09/2003 | CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
| 09/04/2003 | WO2003072567A1 Novel fused ring compounds, and their use as cationic photoinitiators |
| 09/04/2003 | WO2003072566A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 09/04/2003 | WO2003072561A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/04/2003 | WO2003072535A2 Substituted hydroxyethylamines |
| 09/04/2003 | WO2003072532A1 Ester compound and medicinal use thereof |
| 09/04/2003 | WO2003051801A3 Synthesis of alpha, beta, beta-trifluorostyrene via in-situ formation of trifluorovinyl metal halide |
| 09/04/2003 | WO2002049647A3 Novel therapeutic use of a thienylcyclohexylamine derivative |
| 09/04/2003 | US20030166978 Novel ruthenium complexes and process for preparing alcoholic compounds using these |
| 09/04/2003 | US20030166963 Using tertiary amine catalyst |
| 09/04/2003 | US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | CA2477607A1 Substituted hydroxyethylamines |
| 09/03/2003 | EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/03/2003 | EP1340746A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/03/2003 | CN1440401A Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor |
| 09/03/2003 | CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides |
| 09/03/2003 | CN1440390A Substituted diamide derivatives useful as motilin antagonists |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1439635A SW diaryl ethylene compounds and preparation and application thereof |
| 09/03/2003 | CN1439631A Substituted sulfamide (thio) carbonyl compounds |
| 09/02/2003 | US6614719 Ultrasonic doppler effect speed measurement |
| 09/02/2003 | US6613942 Glucagon antagonists/inverse agonists |
| 09/02/2003 | US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages |
| 09/02/2003 | US6613805 For therapy and prophylaxis of neurodegenerative diseases such as Alzheimer's disease, Down's syndrome, Parkinson's disease, Creutzfeldt-Jacob disease, amyotrophic sclerosis on lateral fasciculus, multiple sclerosis, and neurological disorders |
| 09/02/2003 | US6613804 Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 09/02/2003 | US6613798 Small organic molecule regulators of cell proliferation |
| 09/02/2003 | US6613782 For treating and/or preventing endothelin dependent conditions, e.g. cardio- and cerebro-vascular disorders such as hypertension, vasoconstriction, congestive heart failure, cerebral disorders, respiratory system disorders |
| 08/28/2003 | WO2003070720A1 Preparation of n-methyl-3-hydroxy- 3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates |
| 08/28/2003 | WO2003070682A1 NON-COVALENT INHIBITORS OF AmpC ß-LACTAMASE |
| 08/28/2003 | WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/28/2003 | WO2003028641A3 Mch receptor antagonists |
| 08/28/2003 | WO2003008404A3 Sulfonium salts as phtoinitiators for radiation curable systems |
| 08/28/2003 | WO2002036588A3 Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis |
| 08/28/2003 | US20030162979 Substituted sulphonylamino(thio)carbonyl compounds |
| 08/28/2003 | US20030162974 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens |
| 08/28/2003 | US20030162965 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
| 08/28/2003 | US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/28/2003 | US20030162799 Squaric acid derivatives |
| 08/28/2003 | US20030162789 4-alkylpiperazine substituted phenol derivative or 4-alkylamide substituted phenols for treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia and Huntinton's disease |
| 08/28/2003 | US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 08/28/2003 | US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis |
| 08/28/2003 | US20030162724 Such as tris(4-(N-alpha-(2-(1H-indol-3-yl)acetyl)-L-lysyl)aminophenyl)methane hydrochloride for treatment of thrombocytopenia |
| 08/28/2003 | US20030162690 Bood anticoagulant |
| 08/28/2003 | CA2477082A1 Preparation of n-methyl-3-hydroxy- 3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates |
| 08/27/2003 | EP1338594A1 Pgd2 receptor antagonistic pharmaceutical compositions |
| 08/27/2003 | EP1337528A2 Benzothiophene derivative compounds, process of preparation and use thereof |
| 08/27/2003 | EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines" |
| 08/27/2003 | EP1337218A2 Substituted felbamate derived compounds |
| 08/27/2003 | EP0901469B1 Arylalkylpiperazine compounds as antioxidants |
| 08/27/2003 | EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 08/27/2003 | EP0846111B1 Syntheses of optically pure compounds useful as garft inhibitors and their intermediates |
| 08/27/2003 | CN1439002A Muscarinic agonists |
| 08/27/2003 | CN1438543A Ring sulfonium and sulfonium oxide and photoacid generator and photoetching glue |
| 08/27/2003 | CN1438224A Method for preparing pure 2-dibenzo-thiazole-sulfide from waste slag of AE-active ester production |
| 08/26/2003 | US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| 08/26/2003 | US6610747 Phenoxybenzylamine derivatives as SSRIs |
| 08/26/2003 | US6610734 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 08/26/2003 | US6610706 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 08/26/2003 | US6610689 Viricides |
| 08/21/2003 | WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
| 08/21/2003 | WO2003024935A3 Substituted pyrazolyl compounds for the treatment of inflammation |
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes |
| 08/21/2003 | US20030158256 (Arylaminoaceamido)acetonitrile derivatives |
| 08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
| 08/21/2003 | US20030158233 Compositions and methods for treating heart failure |
| 08/21/2003 | US20030158209 Amidomethylcarbonyl-substituted piperazine derivatives containing additional amine groups, useful in treating eating, sexual and skin disorders |
| 08/21/2003 | US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders |
| 08/21/2003 | US20030158185 Novel use of phenylheteroakylamine derivatives |
| 08/21/2003 | US20030158155 Mmp-12 inhibitors |
| 08/21/2003 | CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
| 08/20/2003 | EP1336600A2 Dimer-selective RXR modulators and methods for their use |
| 08/20/2003 | EP1335902A1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
| 08/20/2003 | CN1437647A Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds |
| 08/20/2003 | CN1437584A Tricyclic protein kinase inhibitors |